Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Special Drug Use Surveillance of Leuplin PRO for Injection Kit 22.5 mg for "Prostate Cancer"

NCT03209492 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT03209492
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03209492 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Special Drug Use Surveillance of Leuplin PRO for Injection Kit 22.5 mg for "Prostate Cancer"
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
April 1, 2016
Completion date
December 1, 2017
Enrollment
333 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer